230 followers
Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves' orbitopathy. https://t.co/WZyF8UO8b1 https://t.co/fHoAp06Mq8
Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves' orbitopathy. https://t.co/WZyF8UO8b1 https://t.co/fHoAp06Mq8